Schedule 13G ownership disclosure

WEREWOLF THERAPEUTICS INC

Common stock, par value $0.0001 per share (the "Shares") · CUSIP: 95075A107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • PFM Health Sciences, LP

    Shares: 2,905,465.00 · Class: 6.5%

  • PFM Health Sciences GP, LLC

    Shares: 2,905,465.00 · Class: 6.5%

  • Partner Asset Management, LLC

    Shares: 2,905,465.00 · Class: 6.5%

  • Brian D. Grossman

    Shares: 2,905,465.00 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014060
Form type
SCHEDULE 13G/A
Filer
PFM Health Sciences, LP
CIK
CIK 1442756
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SCHEDULE 13G/A | SEC Filings Hub